Filing Details
- Accession Number:
- 0001179110-12-005522
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-21 13:00:00
- Reporting Period:
- 2012-03-19
- Filing Date:
- 2012-03-21
- Accepted Time:
- 2012-03-21 17:04:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1187553 | Laurance H Fuller | Primacy Business Center 2020 Calamos Court, Suite 200 Naperville IL 60563 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares Without Par Value | Acquisiton | 2012-03-19 | 5,211 | $50.65 | 24,814 | No | 4 | M | Direct | |
| Common Shares Without Par Value | Acquisiton | 2012-03-19 | 7,374 | $37.42 | 32,188 | No | 4 | M | Direct | |
| Common Shares Without Par Value | Acquisiton | 2012-03-19 | 6,699 | $41.20 | 38,887 | No | 4 | M | Direct | |
| Common Shares Without Par Value | Disposition | 2012-03-19 | 10,800 | $60.30 | 28,087 | No | 4 | S | Direct | |
| Common Shares Without Par Value | Disposition | 2012-03-19 | 100 | $60.30 | 27,987 | No | 4 | S | Direct | |
| Common Shares Without Par Value | Disposition | 2012-03-19 | 5,055 | $60.30 | 22,932 | No | 4 | S | Direct | |
| Common Shares Without Par Value | Disposition | 2012-03-19 | 1,229 | $60.31 | 21,703 | No | 4 | S | Direct | |
| Common Shares Without Par Value | Disposition | 2012-03-19 | 2,100 | $60.32 | 19,603 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Option (right to buy) | Disposition | 2012-03-19 | 5,211 | $0.00 | 5,211 | $50.65 |
| Common Shares | Option (right to buy) | Disposition | 2012-03-19 | 7,374 | $0.00 | 7,374 | $37.42 |
| Common Shares | Option (right to buy) | Disposition | 2012-03-19 | 6,699 | $0.00 | 6,699 | $41.20 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2002-04-26 | 2012-04-25 | No | 4 | M | Direct |
| 0 | 2003-04-25 | 2013-04-24 | No | 4 | M | Direct |
| 0 | 2004-04-23 | 2014-04-22 | No | 4 | M | Direct |
Footnotes
- Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.
Billionaire Hedge Funds
